299 related articles for article (PubMed ID: 12824819)
1. Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland.
Oomizu S; Boyadjieva N; Sarkar DK
Alcohol Clin Exp Res; 2003 Jun; 27(6):975-80. PubMed ID: 12824819
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor activation inhibits estrogen-stimulated transforming growth factor-alpha gene expression and growth in anterior pituitary, but not in uterus.
Borgundvaag B; Kudlow JE; Mueller SG; George SR
Endocrinology; 1992 Jun; 130(6):3453-8. PubMed ID: 1534540
[TBL] [Abstract][Full Text] [Related]
3. Differences in the interaction between dopamine and estradiol on prolactin release by cultured normal and tumorous human pituitary cells.
Lamberts SW; Verleun T; Hofland L; Oosterom R
J Clin Endocrinol Metab; 1986 Dec; 63(6):1342-7. PubMed ID: 3782422
[TBL] [Abstract][Full Text] [Related]
4. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
Woolf PD
Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
Shah GV; Shyr SW; Grosvenor CE; Crowley WR
Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
[TBL] [Abstract][Full Text] [Related]
6. Absence of D2S dopamine receptor in the prolactin-secreting MMQ pituitary clone: characterization of a wild D2L receptor coupled to native transduction mechanisms.
Ventra C; Meucci O; Grimaldi M; Scorziello A; Porcellini A; Schettini G
J Mol Endocrinol; 1995 Jun; 14(3):375-89. PubMed ID: 7669227
[TBL] [Abstract][Full Text] [Related]
7. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay.
Jarry H; Leonhardt S; Gorkow C; Wuttke W
Exp Clin Endocrinol; 1994; 102(6):448-54. PubMed ID: 7890021
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
Burris TP; Stringer LC; Freeman ME
Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C regulation of prolactin gene expression in lactotroph cells: involvement in dopamine inhibition.
Chuang TT; Caccavelli L; Kordon C; Enjalbert A
Endocrinology; 1993 Feb; 132(2):832-8. PubMed ID: 7678802
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of estrogen-induced anterior pituitary enlargement and arteriogenesis by bromocriptine in Fischer 344 rats.
Elias KA; Weiner RI
Endocrinology; 1987 Feb; 120(2):617-21. PubMed ID: 3803294
[TBL] [Abstract][Full Text] [Related]
11. The role of adenosine 3',5'-monophosphate in dopaminergic inhibition of prolactin release in anterior pituitary cells.
Tam SW; Dannies PS
Endocrinology; 1981 Aug; 109(2):403-8. PubMed ID: 6166464
[TBL] [Abstract][Full Text] [Related]
12. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
13. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
[TBL] [Abstract][Full Text] [Related]
14. Sodium ions: their role and mechanism of action in the control of prolactin release.
Collu R; Lafond J; Marchisio AM; Eljarmak D; Ducharme JR
Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371
[TBL] [Abstract][Full Text] [Related]
15. Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
Day RN; Hinkle PM
Endocrinology; 1988 May; 122(5):2165-73. PubMed ID: 3129281
[TBL] [Abstract][Full Text] [Related]
16. Direct effect of estradiol on the number of dopamine receptors in the anterior pituitary of ovariectomized rats.
Pasqualini C; Bojda F; Kerdelhué B
Endocrinology; 1986 Dec; 119(6):2484-9. PubMed ID: 3780536
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of anterior pituitary phosphoinositide phosphorylase activity by the D2 dopamine receptor.
Jarvis WD; Judd AM; MacLeod RM
Endocrinology; 1988 Dec; 123(6):2793-9. PubMed ID: 2904359
[TBL] [Abstract][Full Text] [Related]
18. Either isoform of the dopamine D2 receptor can mediate dopaminergic repression of the rat prolactin promoter.
McChesney R; Sealfon SC; Tsutsumi M; Dong KW; Roberts JL; Bancroft C
Mol Cell Endocrinol; 1991 Aug; 79(1-3):R1-7. PubMed ID: 1834494
[TBL] [Abstract][Full Text] [Related]
19. Dopamine inhibition of proopiomelanocortin gene expression in the intermediate lobe of the pituitary. Interactions with corticotropin-releasing factor and the beta-adrenergic receptors and the adenylate cyclase system.
Loeffler JP; Demeneix BA; Kley NA; Höllt V
Neuroendocrinology; 1988 Feb; 47(2):95-101. PubMed ID: 2963967
[TBL] [Abstract][Full Text] [Related]
20. Regulation of galanin gene expression in the rat anterior pituitary gland by the somatostatin analog SMS 201-995.
Hyde JF; Howard G
Endocrinology; 1992 Nov; 131(5):2097-102. PubMed ID: 1385097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
